India helps pharmas compete for WHO contracts

The Indian government is planning a subsidy scheme for mid-size drugmakers to bring their facilities in line with WHO manufacturing standards. Most already comply with the standards of the country's Drugs and Cosmetics Act, so officials believe that the facility upgrades will be of limited scope. A proposal now in the works provides an interest subsidy to the qualifying companies. Article

Sponsored By Digital Pharma Europe

Fierce Pharma Marketing is excited to announce the first virtual Digital Pharma Europe!

This summit will profile best-in-class case studies and senior-level discussions from leaders who are innovating the way we look at the intersection of digital technologies and marketing in Europe.